Exosomes as nanocarriers for brain-targeted delivery of therapeutic nucleic acids: advances and challenges
Экзосомы как нанопереносчики для адресной доставки терапевтических нуклеиновых кислот в мозг: достижения и проблемы
2025-06-18
SCID: 54.1/wcmfh2bw
Discuss with AI
blood-brain barrierbrain-targeted deliveryexosome engineeringexosome nanocarrierstherapeutic nucleic acids
Figures from the paper
Abstract (AI)
Recent advancements in gene expression modulation and RNA delivery systems have underscored the immense potential of nucleic acid-based therapies (NA-BTs) in biological research. However, the blood-brain barrier (BBB), a crucial regulatory structure that safeguards brain function, presents a significant obstacle to the delivery of drugs to glial cells and neurons. The BBB tightly regulates the movement of substances from the bloodstream into the brain, permitting only small molecules to pass through. This selective permeability poses a significant challenge for effective therapeutic delivery, especially in the case of NA-BTs. Extracellular vesicles, particularly exosomes, are recognized as valuable reservoirs of potential biomarkers and therapeutic targets. They are also gaining significant attention as innovative drug and nucleic acid delivery (NAD) carriers. Their unique ability to safeguard and transport genetic material, inherent biocompatibility, and capacity to traverse physiological barriers highlight their potential as drug carriers. This review provides a comprehensive overview of current strategies to enhance NAD to the brain, focusing on the emerging potential of exosomes as biocompatible and efficient nanocarriers. It synthesizes recent advances in the use of exosomes for NA-BTs in neurological disorders, comparing their advantages with those of conventional nanodelivery systems and cell-based therapies. Additionally, the review highlights innovative exosome engineering approaches to improve brain-targeted delivery, addresses key methodological limitations such as variability in cargo content, and proposes solutions to enhance standardization and safety. Collectively, these insights highlight the translational potential of exosomes and offer a novel perspective on bridging the gap between fundamental research and clinical application.
Key Findings
1
Exosome engineering strategies can enhance brain targeting and delivery efficiency for therapeutic nucleic acids.
2
Exosomes can protect and transport genetic material, cross physiological barriers, and provide biocompatible carriers for brain-targeted nucleic acid delivery.
3
Recent studies support exosomes as promising nanocarriers for nucleic acid therapies in neurological disorders, with potential advantages over conventional nanodelivery and cell-based approaches.
4
The blood-brain barrier substantially limits delivery of therapeutic nucleic acids to brain neurons and glial cells.
5
Variability in exosome cargo content creates methodological, standardization, and safety challenges that must be addressed for clinical translation.
Research Object
Exosomes as nanocarriers for brain-targeted delivery of therapeutic nucleic acids
Research Subject
Strategies, engineering approaches, advantages, limitations, and safety of exosome-mediated brain-targeted nucleic acid delivery
Publication Details
Publication Date
2025-06-18
Journal
Publisher
ISSN
Cited by
122
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest